Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Dent ; 76: 9-18, 2018 09.
Article in English | MEDLINE | ID: mdl-29959061

ABSTRACT

OBJECTIVES: To answer the focused question, "What are the prevalence of percutaneous injuries (PIs) on dentists, the location with the highest prevalence, and the dental instrument most responsible for these injuries?" As secondary outcomes, the prevalence by geographic location, type of PI, sex distribution, and dentist's specialty were also considered. ELIGIBILITY CRITERIA: Observational descriptive studies investigating the prevalence of percutaneous injuries on dentists were included. SOURCES: Five electronic databases and three partial grey literature searches were performed. RISK OF BIAS: The MAStARI tool assessed the potential risk of bias (RoB) among the studies, while the GRADE approach determined the level of evidence. INCLUDED STUDIES: Among 2284 identified studies, 55 were included. Three studies were classified as low RoB, 17 as moderate RoB, and 35 as high RoB. The sample size ranged from 9 to 4107 dentists. SYNTHESIS OF RESULTS: The PI prevalence in dentists ranged from 7.72% (95% confidence interval [CI]: 0.93-37.59) to 66.74% (95%CI: 29.83-94.51). North America was the most affected region, while South America was the least affected. Differences between sexes were not significant. The dental bur was the most commonly reported dental instrument causing PIs. LIMITATIONS: Owing to the very low GRADE level of evidence, caution should be applied when considering these findings and further research is required. CONCLUSIONS: A high PI prevalence among dentists was noticed, and most were caused by dental burs. These findings imply that PIs should be considered by every dentist and proper measures instituted to reduce their prevalence.


Subject(s)
Dentists , Occupational Injuries , Dentistry/statistics & numerical data , Dentists/statistics & numerical data , Female , Humans , Male , Occupational Injuries/epidemiology , Prevalence , Risk Factors
2.
Histol Histopathol ; 33(7): 705-716, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29345298

ABSTRACT

Leishmania amazonensis is a major etiological agent of human cutaneous leishmaniasis in the Americas; nevertheless there are some reports of this species causing visceral disease in dogs and men. In the present work we have studied a Leishmania strain isolated from a human case of visceral leishmaniasis. We have infected different mouse strains and analyzed the development of the disease, studying the parasite's ability to visceralize and whether this ability is influenced by host genetics. Female BALB/c, C57BL/6, C57BL/10, CBA, DBA/2, and C3H/He mice were subcutaneously infected with 104 L. amazonensis amastigotes. BALB/c, C57BL/6 and C57BL/10 mice were found to be very susceptible to infection, showing lesions that developed to necrosis and ulceration. CBA mice developed a late but severe lesion. DBA/2 mice developed only discrete lesions, while C3H/He mice did not develop any lesions. All mouse strains except C3H/He showed some degree of visceralization, presenting parasites in the spleen, while BALB/c, C57BL/6 and CBA presented parasites also in the liver. Moreover, most of the strains presented high parasite load at the infection site, whereas DBA and C3H/He mice showed low or no parasite load 90 days after infection, respectively. Histopathology corroborates the results, showing that susceptible mice presented an inflammatory reaction with parasites in the skin, lymph nodes and spleen, while strains that are more resistant presented low parasitism and discrete inflammatory reaction. Results indicate that this isolate is extremely virulent, can easily visceralize and that the pathogenesis of leishmaniasis is, at least in part, related to the genetic background of the host.


Subject(s)
Leishmania/parasitology , Leishmaniasis, Visceral/pathology , Leishmaniasis, Visceral/parasitology , Animals , Disease Susceptibility , Female , Humans , Mice
3.
PLoS One ; 10(10): e0122566, 2015.
Article in English | MEDLINE | ID: mdl-26469517

ABSTRACT

Chagas disease is a worldwide public health problem. Although the vectorial transmission of Chagas disease has been controlled in Brazil there are other ways of transmission, such as the ingestion of T. cruzi contaminated food, which ensures the continuation of this zoonosis. Here, we demonstrate the influence of the inoculation route on the establishment and development of the SC2005 T. cruzi strain infection in mice. Groups of Swiss mice were infected intragastrically (IG) or intraperitoneally (IP) with the T. cruzi SC2005 strain derived from an outbreak of oral Chagas disease. The results revealed that 100% of IP infected mice showed parasitemia, while just 36% of IG infected showed the presence of the parasite in blood. The parasitemia peaks were later and less intense in the IG infected mice. Mortality of the IP infected animals was more intense and earlier when compared to the IG infected mice. In the IP infected mice leucopenia occurred in the early infection followed by leucocytosis, correlating positively with the increase of the parasites. However, in the IG infected mice only an increase in monocytes was observed, which was positively correlated with the increase of the parasites. Histopathological analyses revealed a myotropic pattern of the SC2005 strain with the presence of inflammatory infiltrates and parasites in different organs of the animals infected by both routes as well as fibrosis foci and collagen redistribution. The flow cytometric analysis demonstrated a fluctuation of the T lymphocyte population in the blood, spleen and mesenteric lymph nodes of the infected animals. T. cruzi DNA associated with the presence of inflammatory infiltrates was detected by PCR in the esophagus, stomach and intestine of all infected mice. These findings are important for the understanding of the pathogenesis of T. cruzi infection by both inoculation routes.


Subject(s)
Chagas Disease/epidemiology , Chagas Disease/parasitology , Disease Outbreaks , Animals , Brazil/epidemiology , Chagas Disease/blood , Chagas Disease/transmission , Female , Humans , Leukocyte Count , Mice , Parasitemia/blood , Parasitemia/epidemiology , Parasitemia/parasitology , Parasitemia/transmission , Spleen/parasitology , Thymus Gland/parasitology
4.
Exp Parasitol ; 148: 66-72, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25448354

ABSTRACT

Current treatments for leishmaniasis present some difficulties due to their toxicity, the use of the intravenous route for administration and therapy duration, which may lead to treatment discontinuation. The aim of this study is to investigate new treatment alternatives to improve patients well being. Therefore, we evaluated the inhibitory effect of (-)α-bisabolol, a sesquiterpene alcohol found in various essential oils of different plant species, against the promastigotes and intracellular amastigotes forms of Leishmania amazonensis, as well as the cytotoxic, morphological and ultrastructural alterations of treated cells. Promastigotes forms of L. amazonensis were incubated with (-)α-bisabolol to determine the antileishmanial activity of this compound. The cytotoxicity effect was evaluated by testing against J774.G8 cells. After these tests, the infected and uninfected cells with L. amazonensis were used to determine if the (-)α-bisabolol was able to kill intracellular parasites and to cause some morphological changes in the cells. The (-)α-bisabolol compound showed significant antileishmanial activity against promastigotes with a 50% effective concentration of 8.07 µg/ml (24 h) and 4.26 µg/ml (48 h). Against intracellular amastigotes the IC50 (inhibitory concentration) of (-)α-bisabolol (24 h) was 4.15 µg/ml. The (-)α-bisabolol also showed a cytotoxic effect against the macrophage strain J774.G8. The value of 50% cytotoxic concentration was 14.82 µg/ml showing that (-)α-bisabolol is less toxic to macrophages than to the parasite. Ultrastructural studies of treated promastigotes and amastigotes showed several alterations, such as loss of cytoplasmic organelles, including the nucleus, and the presence of lipid inclusions. This study showed that (-)α-bisabolol has promising antileishmanial properties, as it can act against the promastigote forms and is able to penetrate the cell, and is also active against the amastigote forms. About 69% of the promastigotes forms suffered mitochondrial membrane damage after treatment with IC50 of (-)α-bisabolol, suggesting inhibition of the metabolic activity of parasites. These results open new prospects for research that can contribute to the development of products based on essential oils or isolated compounds from plants for the treatment of cutaneous leishmaniasis.


Subject(s)
Antiprotozoal Agents/pharmacology , Leishmania mexicana/drug effects , Sesquiterpenes/pharmacology , Animals , Antiprotozoal Agents/toxicity , Cell Line , Flow Cytometry , Humans , Inhibitory Concentration 50 , Leishmania mexicana/growth & development , Leishmania mexicana/ultrastructure , Macrophages/drug effects , Mice , Mice, Inbred BALB C , Microscopy, Electron, Transmission , Monocyclic Sesquiterpenes , Sesquiterpenes/toxicity
5.
J Infect Dis ; 201(12): 1933-40, 2010 Jun 15.
Article in English | MEDLINE | ID: mdl-20462353

ABSTRACT

Leishmania amazonensis infection was studied in mice to evaluate the evolution of leishmaniasis. The association of different methods, such as lesion kinetics, limiting dilution analysis, and immunohistochemistry, established different levels of susceptibility and resistance. Mice were arranged in 3 groups: susceptible (C57BL/10 and CBA), relatively resistant (DBA/2), and resistant (C3H.He). The histopathological analysis of primary lesions and draining lymph nodes showed a predominance of eosinophils and mast cells in the initial phase of infection in all mice. However, the most susceptible mice presented a greater number of amastigotes and higher tissue damage. The immunoglobulin analysis showed that susceptible mice produced high levels of antibodies, whereas resistant and relatively resistant mice exhibited low production of antibodies. Resistant mice showed parasite persistency in the skin and lymph nodes, suggesting that the infection in these mice can be sustained through the infection of cells such as dendritic cells, fibroblasts, and other cells present in these organs.


Subject(s)
Leishmania mexicana/immunology , Leishmania mexicana/pathogenicity , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/pathology , Animals , Antibodies, Protozoan/blood , Disease Susceptibility , Eosinophils/immunology , Female , Histocytochemistry , Immunity, Innate , Leishmaniasis, Cutaneous/parasitology , Lymph Nodes/parasitology , Lymph Nodes/pathology , Mast Cells/immunology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Inbred DBA , Skin/parasitology , Skin/pathology
6.
Int J Exp Pathol ; 90(1): 52-7, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19200251

ABSTRACT

The main transmission route of Trypanosoma cruzi is by triatomine bugs. However, T. cruzi is also transmitted through blood transfusion, organ transplantation, ingestion of contaminated food or fluids, or is congenital. Sexual transmission, although suggested since the discovery of Chagas' disease, has remained unproven. Sexual transmission would require T. cruzi to be located at the testes and ovaries. Here we investigated whether T. cruzi is present in the gonads of mice infected with 10(4) T. cruzi trypomastigotes from the CL strain. Fourteen days after experimental infection, histopathological examination showed alterations in the extracellular matrix of the lamina propria of the seminiferous tubules. Furthermore, amastigotes were present in seminiferous tubules, within myoid cells, and in the adjacencies of the basal compartment. These results indicate that T. cruzi is able to reach seminiferous tubule lumen, thus suggesting that Chagas' disease could potentially be transmitted through sexual intercourse. Complementary studies are required to demonstrate that Chagas' disease can be transmitted by coitus.


Subject(s)
Chagas Disease/parasitology , Extracellular Matrix/pathology , Seminiferous Tubules/parasitology , Trypanosoma cruzi/isolation & purification , Animals , Chagas Disease/pathology , Chagas Disease/transmission , Disease Models, Animal , Male , Mice , Seminiferous Tubules/pathology , Testis/parasitology , Testis/pathology
7.
Exp Parasitol ; 120(1): 123-5, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18601926

ABSTRACT

We infected Swiss and C57BL/6 female mice in the left hind footpad with 10(4)Leishmania (L.) amazonensis promastigotes in stationary phase. The macroscopic examination showed a nodular non-ulcerated lesion at the site of inoculation and hepatic and spleenic enlargement. Histopathologically, the primary lesion showed an extensive liquefactive necrosis and inflammatory infiltrate, mainly consisting of macrophages filled with amastigotes, and rare lymphocytes. The inflammatory reaction in liver, spleen and kidney showed amyloid deposits. Additionally, C57BL/6 had accentuated amyloidosis in both ovarian cortical and medullar region and inflammatory infiltrates in the pancreas and adrenal gland.


Subject(s)
Amyloidosis/complications , Leishmania mexicana , Leishmaniasis, Cutaneous/complications , Adrenal Glands/pathology , Amyloidosis/parasitology , Amyloidosis/pathology , Animals , Female , Islets of Langerhans/pathology , Kidney/pathology , Liver/pathology , Mice , Mice, Inbred C57BL , Ovary/pathology , Spleen/pathology
8.
Pharmacology ; 67(2): 55-8, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12566848

ABSTRACT

Actinomycin (ActD) is an antibiotic that binds DNA, preventing transcription. When a Trypanosoma cruzi infection in mice is treated with this drug, the parasite loses its ability to multiply, enabling protection. In this study, axenic cultured T. cruzi parasites were exposed to different concentrations of ActD (10, 20, and 50 microg/ml), all of them being able to inhibit growth and to alter the mobility. Nevertheless, the parasites remained alive and motile for at least 14 days. Scanning electron microscopy of trypomastigotes treated with 10 microg/ml of ActD for 24 h showed a modification in their morphology which suggests a change in the parasite cytoskeleton.


Subject(s)
Dactinomycin/pharmacology , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/ultrastructure , Animals , Anti-Bacterial Agents/pharmacology , Humans , Locomotion/drug effects , Locomotion/physiology , Microscopy, Electron, Scanning , Trypanosoma cruzi/growth & development , Trypanosoma cruzi/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...